Abstract
Most dietary recommendations are based on studies of limited power and do not adequately reflect the current knowledge base, particularly with regard to effects of diet on clinical outcomes, the most important endpoint from the patients perspective. In this review we discuses the current state of dietary research, and present a summary of the evidence upon which to base dietary recommendations and guidelines for atherosclerotic vascular disease prevention. We also highlight the complexity and limitations of interpreting current diet-based epidemiological studies in isolation.
Keywords: Fruits, vegetables, fish, legumes, diet, coronary artery disease, trials, metabolic syndrome, mortality
Cardiovascular & Hematological Disorders-Drug Targets
Title: Overview of Dietary Influences on Atherosclerotic Vascular Disease:Epidemiology and Prevention
Volume: 7 Issue: 2
Author(s): G. Neil Thomas, Bernard M. Y. Cheung, Sai Yin Ho, Duncan J. Macfarlane, Han Bing Deng, Sarah M. McGhee, Jean Woo, Tai Hing Lam and Brian Tomlinson
Affiliation:
Keywords: Fruits, vegetables, fish, legumes, diet, coronary artery disease, trials, metabolic syndrome, mortality
Abstract: Most dietary recommendations are based on studies of limited power and do not adequately reflect the current knowledge base, particularly with regard to effects of diet on clinical outcomes, the most important endpoint from the patients perspective. In this review we discuses the current state of dietary research, and present a summary of the evidence upon which to base dietary recommendations and guidelines for atherosclerotic vascular disease prevention. We also highlight the complexity and limitations of interpreting current diet-based epidemiological studies in isolation.
Export Options
About this article
Cite this article as:
Neil Thomas G., Y. Cheung M. Bernard, Yin Ho Sai, Macfarlane J. Duncan, Bing Deng Han, McGhee M. Sarah, Woo Jean, Hing Lam Tai and Tomlinson Brian, Overview of Dietary Influences on Atherosclerotic Vascular Disease:Epidemiology and Prevention, Cardiovascular & Hematological Disorders-Drug Targets 2007; 7 (2) . https://dx.doi.org/10.2174/187152907780830897
DOI https://dx.doi.org/10.2174/187152907780830897 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-Zinc-Binding Inhibitors of MMP-13: GRID-Based Approaches to Rationalize the Binding Process
Current Topics in Medicinal Chemistry Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review
Current Cardiology Reviews Endothelial Dysfunction in Diabetes: The Role of Protein Kinase C
Vascular Disease Prevention (Discontinued) Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Rationale for Development of New Oral Anticoagulants
Cardiovascular & Hematological Disorders-Drug Targets Metabolic Therapy: Lessons from Liver Diseases
Current Pharmaceutical Design Sex Steroids Regulation of Appetitive Behavior
Mini-Reviews in Medicinal Chemistry Treatment of Leukoaraiosis: A Futuristic View
Current Drug Targets Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Current Drug Targets A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
Cardiovascular & Hematological Disorders-Drug Targets Retinoid-Induced Limb Malformations
Current Pharmaceutical Design Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design Protection by Natural Honey Against Hyperhomocysteinemia in Rats
Vascular Disease Prevention (Discontinued) Low-Molecular-Weight-Heparins: A Review of Literature
Vascular Disease Prevention (Discontinued) Inflammaging of Female Reproductive System: A Molecular Landscape
Current Aging Science Lipid-lowering Drug Therapy in Elderly Patients
Current Pharmaceutical Design Aldose Reductase, Oxidative Stress and Diabetic Cardiovascular Complications
Cardiovascular & Hematological Agents in Medicinal Chemistry Circulating Microparticles as Therapeutic Targets in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery